Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
210.68
-33.67 (-13.78%)
Jul 22, 2025, 11:08 AM EDT
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 745.00M EUR in the quarter ending June 30, 2025, with 5.46% growth. This brings the company's revenue in the last twelve months to 2.90B, up 5.44% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.
Revenue (ttm)
2.90B EUR
Revenue Growth
+5.44%
P/S Ratio
7.03
Revenue / Employee
292.54K EUR
Employees
9,901
Market Cap
21.71B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Sartorius Stedim Biotech News
- 13 days ago - Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform - Business Wire
- 6 months ago - Sartorius, Sartorius Stedim Biotech shares jump after results beat - Reuters
- 9 months ago - Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Sartorius Stedim Biotech S.A. reports Q3 results - Seeking Alpha
- 1 year ago - Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - 10 stocks for investors looking for ‘wonderful companies at a fair price' - Market Watch
- 1 year ago - Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Call Transcript - Seeking Alpha